Sarepta Therapeutics Inc (SRPT)

Add to Watchlists

Create an Alert

Quickflows

98.24 +1.32 +1.36% NASDAQ Jan 22, 20:00 USD

Sarepta Therapeutics News

Wire

Headline

Time (ET)
Yahoo

Pfizer Stock 2021: A Lean, Mean, Covid-Fighting Machine?

01/22 07:00
Yahoo

Will Sarepta's (SRPT) Overdependence on Exondys 51 Hurt?

01/21 10:35
Yahoo

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

01/15 13:20
Yahoo

The SolarWinds Hack Was Huge. Here’s Why JPMorgan Is Defending the Stock.

01/14 12:28
Yahoo

Sarepta (SRPT) Inks New Gene Editing Research Collaboration

01/14 10:26
Yahoo

IMPORTANT INVESTOR NOTICE: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

01/13 13:00
MT Newswires

Sarepta Therapeutics, Genevant Sciences Unveil Research Collaboration for Neuromuscular Diseases

01/13 11:29
SA Breaking News

Sarepta and Genevant Sciences strike research collaboration deal

01/13 08:43
Globe Newswire

Sarepta Therapeutics and Genevant Sciences Announce Research Collaboration for Lipid Nanoparticle-Based Gene Editing Therapeutics

01/13 08:30
Globe Newswire

Sarepta Therapeutics, Inc. Investors: Company Investigated by the Portnoy Law Firm

01/12 13:30
Yahoo

INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

01/12 10:17
MT Newswires

Analyst Actions: Citigroup Downgrades Sarepta Therapeutics to Neutral from Buy, Sets $108 Price Target

01/12 10:02
Yahoo

Sarepta (SRPT) Looks Good: Stock Adds 9.1% in Session

01/12 08:57
SA Breaking News

Sarepta cut to neutral at Citi after DMD gene therapy trial failure

01/12 06:56
Globe Newswire

SHAREHOLDER ALERT: Barr Law Group Investigating the Officers and Directors of SRPT, PS, RP, and PGZ; Shareholders are Encouraged to Contact the Firm

01/12 06:00
Yahoo

Sarepta Stock Gets Mixed Reviews From Analysts

01/11 20:01
Yahoo

Sarepta Stock Gains as CEO Explains What Went Wrong With Gene-Therapy Trial

01/11 15:11
Yahoo

SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Sarepta Therapeutics, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm

01/11 14:45
Yahoo

SRPT Shareholder Alert - Bronstein, Gewirtz & Grossman, LLC Notifies Investors of Sarepta Therapeutics, Inc. Investigation

01/11 12:00
MT Newswires

Analyst Actions: UBS Cuts Sarepta Therapeutics to Neutral From Buy, PT to $87 From $212 on Duchenne Muscular Dystrophy Treatment Study Results

01/11 08:42

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial

{{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.